HPGC Renmintongtai Pharmaceutical Corp Capital Reinvestment Ratio

Latest as of June 2025: 0.01x

HPGC Renmintongtai Pharmaceutical Corp capital reinvestment ratio. HPGC Renmintongtai Pharmaceutical Corp (600829) has a Capital Reinvestment Ratio of 0.01x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥176.16 Million) in capital expenditures (CN¥1.55 Million). Check 600829 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥176.16 Million
CNY

Capital Expenditures

CN¥1.55 Million
CNY

Data as of

Jun 2025
Most recent filing

Capital Reinvestment Ratio of HPGC Renmintongtai Pharmaceutical Corp (1998–2025)

Capital reinvestment ratio of HPGC Renmintongtai Pharmaceutical Corp from 1998 to 2025. This chart tracks HPGC Renmintongtai Pharmaceutical Corp's Capital Reinvestment Ratio across 22 annual periods. Also explore net asset growth rate of HPGC Renmintongtai Pharmaceutical Corp to track the company's year-over-year net asset growth rate.

HPGC Renmintongtai Pharmaceutical Corp Capital Reinvestment Ratio by Year (1998–2025)

HPGC Renmintongtai Pharmaceutical Corp capital reinvestment ratio by year from 1998 to 2025. For the full cash flow conversion analysis, see cash flow conversion of HPGC Renmintongtai Pharmaceutical Corp.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.06x CN¥299.98 Million CN¥17.16 Million ▼ -17.9%
2024 0.07x CN¥115.44 Million CN¥8.04 Million ▼ -1.2%
2023 0.07x CN¥332.99 Million CN¥23.48 Million ▲ +237.7%
2022 0.02x CN¥307.33 Million CN¥6.42 Million ▲ +33.5%
2018 0.02x CN¥366.45 Million CN¥5.73 Million ▼ -69.3%
2017 0.05x CN¥139.07 Million CN¥7.10 Million ▼ -89.7%
2016 0.50x CN¥46.01 Million CN¥22.81 Million ▲ +365.4%
2015 0.11x CN¥333.99 Million CN¥35.58 Million ▲ +145.1%
2014 0.04x CN¥392.58 Million CN¥17.06 Million ▼ -68.5%
2012 0.14x CN¥221.57 Million CN¥30.56 Million ▼ -59.1%
2010 0.34x CN¥162.99 Million CN¥54.90 Million ▲ +61.6%
2009 0.21x CN¥447.82 Million CN¥93.36 Million ▼ -6.8%
2007 0.22x CN¥191.10 Million CN¥42.76 Million ▼ -40.4%
2006 0.38x CN¥191.13 Million CN¥71.74 Million ▲ +236.1%
2005 0.11x CN¥313.04 Million CN¥34.96 Million ▼ -90.7%
2004 1.20x CN¥60.69 Million CN¥72.69 Million ▼ -56.1%
2003 2.73x CN¥71.65 Million CN¥195.45 Million ▲ +528.6%
2002 0.43x CN¥127.49 Million CN¥55.32 Million ▼ -81.8%
2001 2.39x CN¥14.79 Million CN¥35.35 Million ▲ +142.0%
2000 0.99x CN¥61.85 Million CN¥61.09 Million ▲ +32.3%
1999 0.75x CN¥58.21 Million CN¥43.45 Million ▲ +48.9%
1998 0.50x CN¥41.00 Million CN¥20.55 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow